Navigation Links
The CNIO welcomes the new academic year with a spotlight on cancer genetics
Date:9/5/2012

The Distinguished Seminars series, the most prestigious scientific conferences at the Spanish National Cancer Research Centre (CNIO), welcome the new academic year with a double bill focusing on cancer genetics next Thursday and Friday. The conference schedule will last until next June, with over 30 scientific talks of international excellence.

The Nobel laureate Robert Huber, from the Max Planck Institute of Biochemistry (Germany), will give a talk next Thursday, September 6th, on cellular mechanisms used to degrade faulty or unnecessary proteins, processes whose failure can lead to serious diseases. The lecture, titled Intracellular proteolysis, structures, mechanisms and drug design, will be held at the CNIO Auditorium at 12:00.

On Friday 7th, Peter Campbell, researcher at The Wellcome Trust Sanger Institute (UK) and co-director of the Cancer Genome Project in the UK, will explain what scientists hope to learn from the genomic analysis of 50 different tumour types, and its role in future cancer treatments. The talk is titled Interrogating the architecture of cancer genomes and will also be held at the CNIO Auditorium at 12:00 noon.

A talk by Kári Stefánsson is also scheduled for the first half of September. Stefánsson, a neurologist who will give a lecture on Friday 14th titled The genetics of common traits, works for Decode Genetics (Iceland). A company which thanks to an especial agreement has spent the last years studying the medical and genetic data of Icelanders.

Their latest research, published last month, describes the relationship between paternal age and children's susceptibility to some genetic diseases. On its website, Decode Genetics boasts to have discovered "key genetic risk factors for dozens of common diseases, from cardiovascular diseases to cancer."

This ambitious programme brings world leaders in scientific research to Spain every year. The full programme of the Distinguished Seminars series and other conferences organized by the CNIO is available at www.cnio.es, Scientific Events section.
'/>"/>

Contact: Nuria Noriega
nnoriega@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. 7 pharmaceutical companies join academic researchers to speed TB drug discovery
5. The academic jungle: Ecosystem model reveals why women are driven out of science
6. Athletic field paint steals spotlight from the grass it covers
7. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
8. Embryonic development protein active in cancer growth
9. BRG1 mutations confer resistance to hormones in lung cancer
10. Genetic variation in East Asians found to explain resistance to cancer drugs
11. Beyond the microscope: Identifying specific cancers using molecular analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology: